Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Home
Authors
Posts by Pascale Boulet
Pascale Boulet
5 POSTS
0 COMMENTS
Blog
Are gene-editing therapies patentable? A WIPO side event investigates.
Pascale Boulet
-
December 11, 2018
0
Blog
CJEU Ruling on Truvada recalls ‘evergreening’ goes against public health interests
Pascale Boulet
-
September 10, 2018
0
Blog
How patents, data exclusivity and SPCs interact to extend market exclusivity of medicines: the example of Truvada
Pascale Boulet
-
July 10, 2018
0
Blog
Will the European Court of Justice put a stop to the evergreening of Truvada patents?
Pascale Boulet
-
May 8, 2018
0
Blog
Modifier la législation européenne pour mettre en œuvre la licence d’office en France
Pascale Boulet
-
November 14, 2017
0
